Medios, DE000A1MMCC8

Berenberg reaffirms Buy for Medios stock at EUR 22 target

Published on 10/08/2026 at 14:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Berenberg kept Buy and a EUR 22.00 target for Medios on October 2, 2026. Medios stock costs EUR 10.28 on October 8, 2026 below EUR 17.44.

Aquarellmalerei der Berliner Skyline mit Fernsehturm und Spree im Sonnenuntergang
Medios AG (DE000A1MMCC8) hat ihren Firmensitz in Berlin, dargestellt als stimmungsvolles Aquarellbild der Skyline, Illustration mit AI erstellt.

Medios stock was trading at EUR 10.28 at Lang & Schwarz on October 8, 2026 at 1:47 p.m. CEST. Berenberg Bank maintained its Buy rating and set a EUR 22.00 price target in a report dated October 2, 2026, according to Markets Insider.

Analyst target stays above market price

The EUR 22.00 target is more than twice the Lang & Schwarz price, but it is an analyst assessment rather than a company forecast. The same Markets Insider report also cited Deutsche Bank's EUR 16.00 target dated September 30, 2026, leaving a wide spread between published analyst views.

What does the acquisition add?

Medios completed the acquisition of 74 percent of Caesar & Loretz, known as Caelo, on October 1, 2026. The transaction creates a German platform for active pharmaceutical ingredients and compounding products, according to EQS News. The release says Medios will combine Caelo with Magis Pharma in Belgium and Metapharmaceutical in Spain.

Three milestones define the plan

On August 12, 2026, Medios reported first-half revenue of EUR 1,075 million, up 8.4 percent, while EBITDA pre reached EUR 44 million and the margin was 4.1 percent, according to Yahoo Finance. On September 29, 2026, the company presented a 2031 revenue target of EUR 3.1 billion and adjusted EBITDA target of EUR 170 million, according to WebDisclosure. On October 1, 2026, the Caelo deal added the 74 percent stake described above.

Margin remains the key test

The first-half revenue comparison was positive, but profitability moved in the opposite direction: EBITDA pre declined 5.1 percent year over year to EUR 44 million and the margin fell to 4.1 percent. Management attributed the pressure to product pricing, higher operating expenses and regulatory effects, according to Yahoo Finance. The next scheduled quarterly statement is November 10, 2026.

Trading context and next date

Medios was trading at EUR 10.28 at Lang & Schwarz on October 8, 2026 at 1:47 p.m. CEST. The 52-week range was EUR 9.98 to EUR 17.44 as of October 6, 2026, while market capitalization stood at EUR 277.0 million on that date.

The further course of trading is shown by the continuously updated real-time quote of Medios stock.

Medios stock facts

  • Company: Medios AG
  • ISIN: DE000A1MMCC8
  • WKN: A1MMCC
  • Ticker: ILM1
  • Primary exchange: Frankfurt Stock Exchange, Prime Standard
  • Price Lang & Schwarz (as of October 8, 2026, 1:47 p.m. CEST): EUR 10.28
  • Market capitalization: EUR 277.0 million (as of October 6, 2026)
  • 52-week range: EUR 9.98-EUR 17.44 (as of October 6, 2026)
  • Sector / Industry: Healthcare / Specialty Pharma
  • Index membership: SDAX
  • Next earnings date: November 10, 2026

Market context: Market report DAX.

More news and analyses on Medios stock

Disclaimer...

en | DE000A1MMCC8 | MEDIOS | boerse | 70266414 | bgmi